Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Vertex Pharmaceuticals Incorporated
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Infobox company | name = Vertex Pharmaceuticals Incorporated | logo = Vertex logo.svg | type = [[Public company]] | traded_as = {{ubl|{{NASDAQ|VRTX}}|[[Nasdaq-100]] component|[[S&P 500]] component}} | founded = {{Start date and age|1989}} | location = [[Boston, Massachusetts]], U.S. | key_people = {{Plain list| * [[Reshma Kewalramani]] (president and [[Chief executive officer|CEO]]) * [[Jeffrey Leiden]] ([[chairman]]) * [[David Altshuler (physician)|David Altshuler]] ([[chief scientific officer|CSO]]) }} | industry = {{ubl|[[Pharmaceuticals]] | [[Biotherapy|Biotherapeutics]]}} | products = [[Pharmaceutical]]s | revenue = {{increase}} {{US$|8.93 billion|link=yes}} (2022) | operating_income = {{increase}} {{US$|4.31 billion}} (2022) | net_income = {{increase}} {{US$|3.32 billion}} (2022) | assets = {{increase}} {{US$|18.2 billion}} (2022) | equity = {{increase}} {{US$|13.9 billion}} (2022) | num_employees = 4,800 (2022) | website = {{url|vrtx.com}} | footnotes = <ref name=2022-AR>{{cite web |url=https://www.sec.gov/ix?doc=/Archives/edgar/data/875320/000087532023000007/vrtx-20221231.htm |title=Vertex Pharmaceuticals Inc. 2022 Annual Report (Form 10-K) |date=February 10, 2023 |publisher=[[U.S. Securities and Exchange Commission]]}}</ref><ref>{{cite web |url=http://www.hoovers.com/company/Vertex_Pharmaceuticals_Incorporated/rhytri-1.html |title=Vertex Pharmaceuticals Incorporated |publisher=[[Hoover's]] |access-date=24 June 2012}}</ref> }}
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)